Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Asset Utilization Ratio: 2021-2025

Historic Asset Utilization Ratio for Rhythm Pharmaceuticals (RYTM) over the last 4 years, with Sep 2025 value amounting to 0.40.

  • Rhythm Pharmaceuticals' Asset Utilization Ratio rose 31.29% to 0.40 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.40, marking a year-over-year increase of 31.29%. This contributed to the annual value of 0.36 for FY2024, which is 65.79% up from last year.
  • Rhythm Pharmaceuticals' Asset Utilization Ratio amounted to 0.40 in Q3 2025, which was down 3.69% from 0.41 recorded in Q2 2025.
  • In the past 5 years, Rhythm Pharmaceuticals' Asset Utilization Ratio registered a high of 0.41 during Q2 2025, and its lowest value of 0.01 during Q4 2021.
  • For the 3-year period, Rhythm Pharmaceuticals' Asset Utilization Ratio averaged around 0.28, with its median value being 0.31 (2024).
  • Data for Rhythm Pharmaceuticals' Asset Utilization Ratio shows a peak YoY soared of 565.26% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Rhythm Pharmaceuticals' Asset Utilization Ratio stood at 0.01 in 2021, then surged by 565.26% to 0.06 in 2022, then spiked by 268.16% to 0.23 in 2023, then soared by 52.74% to 0.34 in 2024, then spiked by 31.29% to 0.40 in 2025.
  • Its last three reported values are 0.40 in Q3 2025, 0.41 for Q2 2025, and 0.35 during Q1 2025.